Account Information

  • My Account

    Manage all your subscriptions, update your address, email preferences and change your password.

  • Help Center

    Get answers to common service questions, ask the analyst or contact our customer service department.

  • My Stock Talk Profile

    Update your stock talk name and/or picture.



Close

Dividend Investing

Dividend Investing is the time-tested strategy to building wealth in the stock market through passive income streams. From Warren Buffet to John Paulson, many of the top stock market billionaires live comfortably on the passive income streams generated through dividend investing. Check out the dividend investing archive below to uncover high-yielding dividend stock ideas, dividend trends, and tax-saving tips. For more invaluable insight all dividend investors should consider, check out our free reports: 5 High Yield Dividend Stocks and The Income Investors Blacklist.

Something to Chat About

Subscribers have questions, and, once a month, I do my best to provide answers. Here’s the transcript of the March 2015 UF/CE/AE online chat.

A European “Good Enough” Bull Market Begins

We strongly believe Europe still has the best prospects for growth after the United States.

The Reemerging Celtic Tiger

Ireland is the fastest growing economy in the EU, and investors are seeing green. 

How Do Essential-Service Stocks Perform When Rates Are Rising?

A focus on high-quality companies to the exclusion of factors out of our control is the way we’ll build wealth over the long term.

Global Stress Test

Which industries and countries are particularly vulnerable to a crash.

Banking on European Profits

Europe's stimulus should boost two of our highest-yield holdings.

The Deflation Wolf at the Door

Invest in these companies built with brick. 

Title II, ISPs and the Future of the Internet

The Federal Communications Commission, in a party-line, 3-2 vote, approved rules that it believes will further the cause of “net neutrality.”

Two Strong Divisions Give Glaxo a Shot in the Arm

A possible spin-off of its HIV unit adds to the stock’s potential.

Two Strong Divisions Give Glaxo a Shot in the Arm

A possible spin-off of its HIV unit adds to the stock’s potential.

Page 2 of 5512345...Last »